Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO, Director
-
Stock Symbol
-
TRML on Nasdaq
Sandeep Chidambar Kulkarni - trading volume in the past year for Tourmaline Bio, Inc.
Holdings reported by Sandeep Chidambar Kulkarni for Tourmaline Bio, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
7K |
$104K |
$14.85 |
Aug 21, 2024 |
By Gilead Capital, LP |
|
|
| Employee Stock Option (Right to Buy) |
254K |
|
|
Oct 23, 2023 |
Direct |
Common Stock |
|
Transactions reported by Sandeep Chidambar Kulkarni for Tourmaline Bio, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.